26 related articles for article (PubMed ID: 8962421)
1. Serum IGF-1, IGFBP-3 and their ratio: Potential biochemical growth maturity indicators.
Jain N; Tripathi T; Gupta SK; Rai P; Kanase A; Kalra S
Prog Orthod; 2017 Dec; 18(1):11. PubMed ID: 28459119
[TBL] [Abstract][Full Text] [Related]
2. The time of the insult/triggering event in Legg-Calvé-Perthes' disease determined by incubation period modeling and the age distribution of children with Perthes'.
Loder RT; Browne RH; Millis A; Kim WC; Shah H; Cosgrove AP; Wiig O
Iowa Orthop J; 2012; 32():69-75. PubMed ID: 23576924
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic Gene Variants Identified in Patients Presenting With Perthes or Perthes-like Hip Disorder.
Marchelli G; Mercado C; Gill CS; Kim HKW
J Pediatr Orthop; 2024 Apr; ():. PubMed ID: 38651529
[TBL] [Abstract][Full Text] [Related]
4. Aetiology of Legg-Calvé-Perthes disease: A systematic review.
Pavone V; Chisari E; Vescio A; Lizzio C; Sessa G; Testa G
World J Orthop; 2019 Mar; 10(3):145-165. PubMed ID: 30918798
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology and demographics of legg-calvé-perthes' disease.
Loder RT; Skopelja EN
ISRN Orthop; 2011; 2011():504393. PubMed ID: 24977062
[TBL] [Abstract][Full Text] [Related]
6. Monozygotic Twins with Legg-Calvé-Perthes Disease and with Non-Identical Lumbosacral Malformation: a Case Report and Literature Review.
Hrubá M; Bárta P; Džupa V; Krbec M
Acta Chir Orthop Traumatol Cech; 2023; 90(5):353-357. PubMed ID: 37898500
[TBL] [Abstract][Full Text] [Related]
7. Decreased levels of IGF binding protein-3 in serum from children with Perthes' disease.
Matsumoto T; Enomoto H; Takahashi K; Motokawa S
Acta Orthop Scand; 1998 Apr; 69(2):125-8. PubMed ID: 9602767
[TBL] [Abstract][Full Text] [Related]
8. Serum insulin-like growth factors IGF-I and IGFBP-3 in children with slipped capital femoral epiphysis.
Nicolai RD; Grasemann H; Oberste-Berghaus C; Hövel M; Hauffa BP
J Pediatr Orthop B; 1999 Apr; 8(2):103-6. PubMed ID: 10218170
[TBL] [Abstract][Full Text] [Related]
9. Normal plasma levels of IGF binding protein in Perthes' disease. Follow-up of previous report.
Neidel J; Schönau E; Zander D; Rütt J; Hackenbroch MH
Acta Orthop Scand; 1993 Oct; 64(5):540-2. PubMed ID: 7694440
[TBL] [Abstract][Full Text] [Related]
10. Effects of iodine deficiency on insulin-like growth factor-I, insulin-like growth factor-binding protein-3 levels and height attainment in malnourished children.
Wan Nazaimoon WM; Osman A; Wu LL; Khalid BA
Clin Endocrinol (Oxf); 1996 Jul; 45(1):79-83. PubMed ID: 8796142
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
[TBL] [Abstract][Full Text] [Related]
12. Skeletal immaturity, IGF-I and IGFBP-3 serum concentrations in Legg-Calvé-Perthes disease (skeletal immaturity, IGF-I and IGFBP-3 in LCPD).
Grasemann H; Nicolai RD; Hauffa BP; Reinhardt W; Nicolai H; Hövel M
Klin Padiatr; 1996; 208(6):339-43. PubMed ID: 8962421
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
